1-c2亚烷基、nr、o或s(o)n; [0017] x2是o或nh; [0018] x3是n或ch; [0019] n是0、1或2; [0020] r是氢、氰基、任选被取代的c 1-c4烷基、任选被取代的c 2-c4烯基、任选被取代的c 2-c4炔基、c(o)r’、c(o)or’、c(o)n(r’)2、s(o)r’、s(o)2r’或s(o)2n(r’)2; [0021...
<?php $private_key = <<<KEY ---BEGIN RSA PRIVATE KEY--- MIICXQIBAAKBgQC6BSDlbRplhMMNZBKHX4xe8AwESpzHVfAcHHsX9FFSMuF91W3c xgT/g5n+qlLLFzCE3hWG/yX5NMAxR4mS3MlhyXKwko3tK9Ua691afod1lxORR3Ia Z8nV7v5Bv8y4JDe4E3/f/bQIGzroWiJ0sXTcO41GqvOw3G9leClSvjVnSwIDAQAB AoGAagooYYCbTomq4w...
在建立HEC-RAS几何模型时,另一项重要的工作就是确定粗糙度系数,即曼宁系数n,其取值会对计算结果产生很大影响,其影响大小会在下文中进行分析。《HEC-RAS水力参考手册4.0》[50](下文中简称为《手册》)中列出了曼宁系数n取值的影响因素,包括...
J. & Weis, W. I. α-Catenin and IQGAP regulate myosin localization to control epithelial tube morphogenesis in Dictyostelium. Dev. Cell 23, 533–546 (2012). Article CAS PubMed PubMed Central Google Scholar Schneider, N. et al. A Lim protein involved in the progression of cytokinesis ...
(n = 19). The CNS failure rate was 37% (7 out of 19 patients), with only two patients experiencing CNS progression in the KRYSTAL-1 trial [138]. Therefore, Adagrasib may currently be the first choice for patients with KRASG12C-mutant NSCLC. However, Phase 3 studies will be ...
Saved searches Use saved searches to filter your results more quickly Cancel Create saved search Sign in Sign up Reseting focus {{ message }} carpdiem / raspi_neopixel_lights Public Notifications You must be signed in to change notification settings Fork 0 Star 0 ...
Cell 140, 209–221 (2010). Article CAS PubMed PubMed Central Google Scholar Poulikakos, P. I., Zhang, C., Bollag, G., Shokat, K. M. & Rosen, N. RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF. Nature 464, 427–430 (2010). References ...
室内机尺寸780×280×221mm 室内机重量8kg 室外机尺寸750×548×288mm 室外机重量31kg 日立RAS/C-35AVY(SEER2级)空调 相关产品及性能比较 与同价位空调产品比较与同品牌空调产品比较 大金FVXG72JV2CW6(3P) 大金FVXF172MC-N(3P) 大金FVXG60JV2CW2(2.5P) ...
& Bishop, W. R. Lipid posttranslational modifications. Farnesyl transferase inhibitors. J. Lipid Res. 47, 15–31 (2006). CAS PubMed Google Scholar Berndt, N., Hamilton, A. D. & Sebti, S. M. Targeting protein prenylation for cancer therapy. Nat. Rev. Cancer 11, 775–791 (2011). ...
(R )‑,其中碳结合至‑N(R )C(O)‑的羰基碳;任选被取代的3至6元亚环烷基;任 选被取代的3至6元亚杂环烷基;任选被取代的6元亚芳基;或5至6元亚杂芳基; L不存在或为连接体; W是氢、任选被取代的氨基、任选被取代的C ‑C 烷氧基、任选被取代的C ‑C 羟基烷基、任 1 4 1 4 选被取代...